Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds

Radiotherapy and Oncology

Volumn 82, Issue 1, 2007, Pages 46-49

  Bottomley, David ^a   Ash, Dan ^a   Al Qaisieh, Bashar ^b   Carey, Brendan ^a   Joseph, Joji ^a   St Clair, Shaun ^b   Gould, Kathy ^a  

^a Regional Cancer Treatment Centre

^b Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Morbidity; Prostate brachytherapy; Radiation toxicity

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CATHETERIZATION; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; IMPLANT; INTERNATIONAL PROSTATE SYMPTOM SCORE; INTESTINE FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEEDLE; ORGAN SIZE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; RADIATION INJURY; RISK ASSESSMENT; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION; URINE INCONTINENCE;

ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; HUMANS; IMPOTENCE; IODINE RADIOISOTOPES; LOGISTIC MODELS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RISK; URETHRITIS; URINARY INCONTINENCE; URINARY RETENTION;

EID: 33846250457     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.11.006     Document Type: Article

References (26)

1. Battermann J.J., Boon T.A., and Moerland M.A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol (2004) 23-28
2. Brackman B.G., Thomas D., Hilby J., et al. Failure free survival following brachytherapy alone or external beam irradiation alone for T1 to T2 prostate tumours in 2222 patients; results from a single practice. Int J Radiat Oncol Biol Phys 48 (2000) 111-117
3. Buskirk S.J., Pinkstaff D.M., Petrou S.B., et al. Acute urinary retention after transperineal template guided prostate biopsy. Int J Radiat Oncol Biol Phys 59 (2004) 1360-1366
4. Eapen L., Kayser C., Deshaies Y., et al. Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity. Int J Radiat Oncol Biol Phys 59 (2004) 1392-1394
5. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
6. Grimm P.D., Blasko J.C., and Ragde H. Ultrasound guided transperineal implantation of iodine 125 and palladium 103 for the treatment of early stage prostate cancer - technical concepts in planning, operative technique and evaluation. Atlas Urol Clin M Am 2 (1994) 113-125
7. Gutman S., Merrick G.S., Butler W.M., et al. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent brachytherapy. BJU Int 97 (2006) 62-68
8. Henderson A.S., Ismail A.K., Cunningham M., et al. Toxicity and early biochemical outcomes from Iodine 125 prostate brachytherapy in the UK. A prospective study. Clin Oncol 16 (2004) 95-104
9. Joseph J., Al-Qaisieh B., Ash D., et al. Prostate specific antigen relapse free survival in patients with localised prostate cancer treated by brachytherapy. BJU Int 94 (2004) 1235-1238
10. McElveen T.L., Waterman F.M., Kim H., et al. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1395-1404
11. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52 (2002) 893-902
12. Merrick G.S., Butler W.M., Wallner K.E., et al. Brachytherapy-related dysuria. BJU Int 95 (2005) 597-602
13. Ohashi T., Yorozu A., Toya K., et al. Serial changes of international prostate symptom score following I125 prostate brachytherapy. Int J Clin Oncol 11 (2006) 320-325
14. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1 to T2 prostate cancer; radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
15. Potters L., Morganstern C., Calugaru E., et al. 12 year outcomes following permanent prostate brachytherapy in patients with clinically localised prostate cancer. J Urol 173 (2005) 1562-1566
16. Potters L., Torr T., Fearn P.A., et al. Potency after permanent prostate brachytherapy for localised prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1235-1242
17. Ramos C.G., Carvalhal G.F., and Smith D.S. Retrospective comparison of radical retropubic prostatectomy and iodine 125 brachytherapy for localised prostate cancer. J Urol 161 (1999) 1212-1215
18. Robinson J.W., Mortitz S., and Fung T. Meta-analysis of rates of erectile function after treatment of localised prostate carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 1063-1068
19. Shah J.N., and Ennis R.D. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. IJ Radiat Oncol Biol Phys 64 (2006) 817-824
20. Snyder K.M., Stock R.G., Hong S.M., et al. Defining the risk of developing grade 2 proctitis following iodine 125 prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50 (2001) 335-341
21. Stone N.N., and Stock R.G. Complications following permanent prostate brachytherapy. Eur Urol 41 (2002) 427-433
22. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
23. Wallner K., Roy J., and Harrison L. Tumour control and morbidity following transperineal iodine 125 implantation for stage T1-T2 prostate carcinoma. J Clin Oncol 14 (1996) 449-453
24. Waterman F.M., and Dicker A.P. Probability of late rectal morbidity in iodine 125 prostate brachytherapy. Int J Radait Oncol Biol Phys 55 (2003) 342-353
25. Wei J.J., Dunn R.L., Litwin M.S., et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
26. Zelefsky M.J., Hollister T., Raben A., et al. Five year biochemical outcome and toxicity with transperineal CT planned permanent iodine 125 prostate implantation for patients with localised prostate Cancer. Int J Radiat Oncol Biol Phys 47 (2000) 1261-1266